Skip to main content
Explore URMC


Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Waldenström Macroglobulinemia

Research Question:
What is the response of the immune system when patients with chronic lymphocytic leukemia are vaccinated with the Shingrix herpes zoster vaccine?

Basic Study Information

The purpose of this study is to measure humoral response 4 weeks after vaccination with the Shingrix herpes zoster vaccine in patients with CLL and WM undergoing first-line treatment with BTK inhibitors.

Study Reference #: ULYM18094

Lead Researcher (Principal Investigator)

Lead Researcher: Jonathan Friedberg, MD

Study Contact Information

Study Coordinator: Delaney Dretto
Phone: (585) 275-5825

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search